本页面由Tiger Trade Technology Pte. Ltd.提供服务

Century Therapeutics, Inc.

2.02
-0.0400-1.94%
盘后2.00-0.0200-0.99%19:12 EDT
成交量:155.00万
成交额:308.68万
市值:3.64亿
市盈率:-18.25
高:2.05
开:2.02
低:1.93
收:2.06
52周最高:3.04
52周最低:0.3418
股本:1.80亿
流通股本:1.12亿
量比:0.61
换手率:1.38%
股息:- -
股息率:- -
每股收益(TTM):-0.1107
每股收益(LYR):-0.1107
净资产收益率:-5.98%
总资产收益率:-3.26%
市净率:2.29
市盈率(LYR):-18.25

数据加载中...

公司资料

公司名字:
Century Therapeutics, Inc.
交易所:
NASDAQ
成立时间:
2018
员工人数:
78
公司地址:
25 North 38th Street,11th Floor,Philadelphia,Pennsylvania,United States
邮编:
19104
电话:
传真:
- -
简介:
Century Therapeutics, Inc.于2018年3月5日在特拉华州注册成立。该公司是一家专注于开发用于自身免疫性疾病和癌症的异体多能干细胞疗法的生物技术公司。其平台利用诱导多能干细胞生成多种细胞类型,包括胰岛β细胞和免疫细胞,并通过专有技术进行工程化改造以防止宿主免疫排斥。

董事

名称
职位
Brent Pfeiffenberger
Director,President and Chief Executive Officer,Chairman of the Board
Alessandro Riva
Independent Director
Daphne E. Quimi
Independent Director
Kimberly Blackwell
Independent Director
Timothy P. Walbert
Independent Director
Han Lee
Director
Martin Murphy
Director

股东

名称
职位
Brent Pfeiffenberger
Director,President and Chief Executive Officer,Chairman of the Board
Douglas Carr
Senior Vice President, Finance,Interim Principal Financial Officer
Chad Cowan
Chief Scientific Officer
Gregory Russotti
Chief Technology and Manufacturing Officer
Hyam Levitsky
President of Research and Development